PFIZER IGNITE
Swiss trademark · 797552 · Word mark · In force
Register entry
- Registration number
- 797552
- Application number
- 00973/2023
- Status
- In force
- Type
- Word mark
- Filed
- Jan 25, 2023
- Registered
- May 17, 2023
- Published
- May 17, 2023
- Protected until
- Jan 25, 2033
- Language of procedure
- German
- Source
- Swissreg
Goods and services
Treatment of materials
Kundenspezifische Herstellung von Pharmazeutika auf Bestellung und nach den Anforderungen eines Kunden.
Science, technology and IT
Pharmazeutische Forschung und Entwicklung; Durchführung klinischer Studien für Dritte; Platform as a Service (PaaS), nämlich Zurverfügungstellung von Plattformen für die Arzneimittelentwicklung.
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jun 27, 2024
Agent removed
- Representative
- BOVARD SA, Conseils en propriété intellectuelle, Optingenstrasse 16, 3013 Berne (removed)
Published in Swissreg on 27.06.2024
- Jun 27, 2024
Agent entered
- Representative
- E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich
Published in Swissreg on 27.06.2024
- Aug 23, 2023
Agent removed
- Representative
- E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich (removed)
Published in Swissreg on 23.08.2023
- Aug 23, 2023
Agent entered
- Representative
- BOVARD SA, Conseils en propriété intellectuelle, Optingenstrasse 16, 3013 Berne
Published in Swissreg on 23.08.2023
- Aug 23, 2023
Holder’s address changed
- Owner
- Pfizer Inc., 235 East 42nd Street, New York, NY 10017, USA → Pfizer Inc., 66 Hudson Boulevard East, New York, NY 10001-2192, USA
Published in Swissreg on 23.08.2023
- May 17, 2023
Registered
Published in Swissreg on 17.05.2023
Parties
The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.